TRASTUZUMAB DERUXTECAN

trastuzumab deruxtecan 100 mg injection, 1 vial

TRASTUZUMAB DERUXTECAN (13718B)

trastuzumab deruxtecan 100 mg injection, 1 vial
13718B
Body System:
Manner of administration:Injection
Public
Chemotherapy Items for Public Hospital use
Authority Required

Restriction

Indication: Metastatic (Stage IV) HER2 positive breast cancer
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 675 mg # of repeats: 8 DPMA: $17,542.65 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Enhertu
(trastuzumab deruxtecan 100 mg injection, 1 vial)